Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Triazolam Trial In Healthy Subjects To Compare Bioavailability Between Formulations Of Triazolam To Determine Their Bioequivalence In Terms Of Rate And Magnitude Of Absorption

This study has been withdrawn prior to enrollment.
Investigación Farmacológica y Biofarmacéutica
Information provided by:
Pfizer Identifier:
First received: November 20, 2009
Last updated: April 4, 2016
Last verified: April 2016
No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: September 2010
  Estimated Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)